Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001213916 | SCV001385572 | likely benign | Short-rib thoracic dysplasia 10 with or without polydactyly; Retinitis pigmentosa 71 | 2024-12-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004548070 | SCV004113136 | uncertain significance | IFT172-related disorder | 2023-10-03 | criteria provided, single submitter | clinical testing | The IFT172 c.59C>T variant is predicted to result in the amino acid substitution p.Thr20Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.091% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-27708351-G-A). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Ambry Genetics | RCV004986951 | SCV005604259 | uncertain significance | Inborn genetic diseases | 2024-09-04 | criteria provided, single submitter | clinical testing | The c.59C>T (p.T20I) alteration is located in exon 2 (coding exon 2) of the IFT172 gene. This alteration results from a C to T substitution at nucleotide position 59, causing the threonine (T) at amino acid position 20 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |